| Patent application number | Description | Published |
|---|
| 20100260698 | Anhydrous Antiperspirant Compositions with Improved Active Substance Release - Antiperspirant compositions for personal body care, ready-made as a stick, soft solid, cream, gel, suspension, solution or impregnated on a substrate, containing at least one antiperspirant active substance, at least one oil, liquid under normal conditions, as a carrier, 0-3 wt. % by weight of free water, based on weight of the composition, and at least one organosiloxane oxyalkylene copolymer. | 10-14-2010 |
| 20110091402 | ANTIPERSPIRANT PRODUCTS AND PROCESSES FOR FABRICATING THE SAME - Antiperspirant products and processes for making them are provided. In one embodiment, an antiperspirant product comprises an active antiperspirant compound and a carrier having a first volatility rate in an air ambient at about 50° C. and 1 atm after a first time period and a second volatility rate in an air ambient at about 50° C. and 1 atm after a second time period, wherein the second volatility rate is less than the first volatility rate and the first time period is less than the second time period. | 04-21-2011 |
| Patent application number | Description | Published |
|---|
| 20090131701 | Process for Enzymatic Production of Triglycerides - A process for enzymatic production of glyceride compositions, specifically industrially practicable production of triglycerides, including conjugated linoleic and linolenic acid triglycerides, and the compositions produced by such process. An enzymatic reaction zone is first utilized, in which a mixture of glycerol and fatty acids or fatty acid derivatives is reacted in the presence of an enzymatic catalyst to form 1,3 diglycerides. The mixture is then circulated through a second thermal rearrangement zone, maintained at a higher temperature, to promote rearrangement of the 1,3 diglycerides to 1,2 diglycerides. Triglycerides are produced by re-circulating the mixture through the enzymatic production zone. | 05-21-2009 |
| 20090197952 | Glyceride Esters for the Treatment of Diseases Associated with Reduced Neuronal Metabolism of Glucose - Provided are alternative sources of ketone bodies for reducing or eliminating symptoms of Parkinson's disease, amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease), Alzheimer's disease, Huntington's disease, epilepsy and other diseases or disorders characterized by impaired glucose metabolism. The alternative sources of ketone bodies include mono-, di- and triglyceride esters of acetoacetate and mixtures thereof, and/or mono-, di- and triglyceride esters of 3-hydroxybutyrate and mixtures thereof. These glyceride esters can be administered orally as a dietary supplement or in a nutritional composition. | 08-06-2009 |
| 20100036142 | Process for Preparing Conjugated Linoleic Acid and Derivatives Thereof from Ricinoleic Acid - A process for preparing conjugated linoleic acid (CLA) or derivatives thereof from ricinoleic acid, lower alkyl esters of ricinoleic acid, or salts thereof. The CLA is formed by reacting a carboxylic acid, or anhydride, anhydride equivalent, or ester thereof with the ricinoleic acid or derivative to form an intermediate having a carboxylic ester at the 12-hydroxy position of the ricinoleic acid or derivative, and reacting the intermediate with a base to form a cis-9, trans-11 conjugated linoleic acid. | 02-11-2010 |
